174 results
8-K
EX-99.1
AGRX
Agile Therapeutics Inc
15 May 24
Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
4:15pm
15, 2024 (GLOBE NEWSWIRE) – Agile Therapeutics, Inc. (Pink: AGRX), a women's healthcare company, today reported financial results for the three … Agile Therapeutics, Inc.
Agile Therapeutics is a women's healthcare company dedicated to fulfilling the unmet health needs of today’s women. Our product
8-K
EX-99.1
AGRX
Agile Therapeutics Inc
9 Apr 24
Results of Operations and Financial Condition
8:30am
or circumstances.
NASDAQ: AGRX Company & Product Overview 3
NASDAQ: AGRX Agile Therapeutics® is a commercial-stage women’s healthcare company dedicated
8-K
EX-99.1
5ta918o5954s6jjurl
28 Mar 24
Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update
9:06am
8-K
EX-99.1
3im8rv gi
25 Mar 24
Agile Therapeutics Announces Delisting from Nasdaq
4:30pm
8-K
EX-99.1
41vge7im7vx am2
14 Mar 24
Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution
4:45pm
8-K
EX-99.1
z7mr8iqeonm
23 Feb 24
Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds
4:30pm
8-K
EX-99.1
5lt704hxul4
15 Feb 24
Net Revenue for Full Year 2023 Expected to be in the Range of $20 to $21 Million, an Increase of 84% to 93% Compared to Full Year 2022
4:45pm
8-K
EX-99.1
yrp8gzs4mgb69fd9zg
9 Nov 23
Agile Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
8:15am
8-K
EX-99.1
tbtcndjzd08iulqd08o
9 Aug 23
Agile Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
8:10am
8-K
EX-99.1
cfloe8nflr7lcy2vgsz
25 May 23
Agile Therapeutics Announces Pricing of $7.5 Million Public Offering
5:25pm
8-K
EX-99.2
pgnoy5dj5t9d 5c
25 May 23
Agile Therapeutics Announces Pricing of $7.5 Million Public Offering
5:25pm
424B4
wpgbe1
24 May 23
Prospectus supplement with pricing info
4:05pm